[go: up one dir, main page]

AR016200A1 - THE USE OF A COMPOSITION THAT INCLUDES ONE OR MORE COMPOUNDS CONTAINING SULFUR FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO INCREASE THE PERMEABILITY OF THE HUMAN CORN FABRIC, AND A KIT THAT INCLUDES SUCH COMPOSITION - Google Patents

THE USE OF A COMPOSITION THAT INCLUDES ONE OR MORE COMPOUNDS CONTAINING SULFUR FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO INCREASE THE PERMEABILITY OF THE HUMAN CORN FABRIC, AND A KIT THAT INCLUDES SUCH COMPOSITION

Info

Publication number
AR016200A1
AR016200A1 ARP990101431A ARP990101431A AR016200A1 AR 016200 A1 AR016200 A1 AR 016200A1 AR P990101431 A ARP990101431 A AR P990101431A AR P990101431 A ARP990101431 A AR P990101431A AR 016200 A1 AR016200 A1 AR 016200A1
Authority
AR
Argentina
Prior art keywords
composition
permeability
kit
manufacture
increase
Prior art date
Application number
ARP990101431A
Other languages
Spanish (es)
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of AR016200A1 publication Critical patent/AR016200A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

El uso de una composicion que comprende uno o más compuestos que contienen azufre para la fabricacion de un medicamento util para aumentar la permeabilidaddel tejido corneo humano a los agentes activos, caracterizado porque consiste en una cantidad efectiva de uno o más compuestos que contienen azufre al tejidocorneo humano durante un período de tiempo suficiente para aumentar la permeabilidad del tejido corneo humano a los agentes activos, y un kit que incluye dichacomposicion.The use of a composition comprising one or more sulfur-containing compounds for the manufacture of a medicament useful for increasing the permeability of human corneal tissue to active agents, characterized in that it consists of an effective amount of one or more sulfur-containing compounds to the corneal tissue. human for a period of time sufficient to increase the permeability of the human corneal tissue to the active agents, and a kit that includes said composition.

ARP990101431A 1998-03-31 1999-03-30 THE USE OF A COMPOSITION THAT INCLUDES ONE OR MORE COMPOUNDS CONTAINING SULFUR FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO INCREASE THE PERMEABILITY OF THE HUMAN CORN FABRIC, AND A KIT THAT INCLUDES SUCH COMPOSITION AR016200A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8021298P 1998-03-31 1998-03-31

Publications (1)

Publication Number Publication Date
AR016200A1 true AR016200A1 (en) 2001-06-20

Family

ID=22155965

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101431A AR016200A1 (en) 1998-03-31 1999-03-30 THE USE OF A COMPOSITION THAT INCLUDES ONE OR MORE COMPOUNDS CONTAINING SULFUR FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO INCREASE THE PERMEABILITY OF THE HUMAN CORN FABRIC, AND A KIT THAT INCLUDES SUCH COMPOSITION

Country Status (4)

Country Link
AR (1) AR016200A1 (en)
AU (1) AU3212099A (en)
CO (1) CO5070608A1 (en)
WO (1) WO1999049895A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
GB0511499D0 (en) * 2005-06-06 2005-07-13 Medpharm Ltd Topical ungual formulations
ATE444071T1 (en) * 2006-08-17 2009-10-15 Klever Mode S L PHARMACEUTICAL COMPOSITIONS FOR TREATING SKIN DISEASES
WO2011155887A1 (en) * 2010-06-07 2011-12-15 Topical Pharma Ab Kit for the treatment of onychomycosis by nitric oxide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956467A (en) * 1988-04-01 1990-09-11 American Cyanamid Company Nucleophilic tertiary organophosphines
IL97012A0 (en) * 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
IT1249047B (en) * 1991-02-21 1995-02-11 Zambon Spa PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CATARACT
FR2681782B1 (en) * 1991-09-26 1993-12-17 Oreal COMPOSITION FOR THE TREATMENT OF NAILS CONTAINING A SULFUR AMINOACID.
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
AU3212099A (en) 1999-10-18
WO1999049895A2 (en) 1999-10-07
WO1999049895A3 (en) 1999-11-18
CO5070608A1 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
ES2183186T3 (en) COSMETIC COMPOSITIONS IN POWDER CONTAINING SILICONE ELASTOMEROS.
KR920019342A (en) Bone Disease Treatment
DE60117043D1 (en) TREATMENT OF MUCOSITIS
BR0009830A (en) Skin care compositions containing a combination of active substances for skin care
NZ597106A (en) Ophthalmic compositions comprising carnitine and methods for treating eyes
ES2058291T3 (en) DERIVATIVES OF PIPERAZINYL FROM PURINE AND ISOSTEROS OF THE SAME AS HYPOGLYCEMIC AGENTS.
AR018286A1 (en) PHARMACEUTICAL COMPOSITION THAT IN QUALITY OF ACTIVE PRINCIPLE CONTAINS THE ASFCIATION OF METFORMIN AND FIBRATE, AND THE USE OF THIS ASSOCIATION TO PREPARE MEDICATIONS
BRPI0017528B8 (en) use of a composition containing ketotifen salt
MX9602806A (en) 1,2,4-oxadiazole derivatives and their use as parasiticides for animals.
ES2044840T3 (en) STABILIZED COMPOSITIONS OF THE HUMAN TISSUE PLASMINOGEN ACTIVATOR.
ATE260650T1 (en) ORAL DOSAGE FORMS FOR ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
CO5001019A1 (en) EMULSIONABLE COMPOSITION FOR THE REPRESSION OF INSECTS, WHICH IS DERIVED FROM THE TYPE OF PHENYLPIRAZOLS REPLACED IN POSITION 1, AND DO NOT FAVOR THE FORMATION OF CRYSTALS
ES2011232T3 (en) PHARMACEUTICAL COMPOSITIONS OF PIROXICAM IN AQUEOUS SOLUTIONS AND PROCEDURE FOR ITS PREPARATION.
BR0304298A (en) Composition containing a cosmetically active organic acid and a vegetable product
BR0015392A (en) Lipoxin a4 and its analogs for the treatment of dry eye
BR9814299A (en) Aminobiguanides and their use for contact disinfectants and to preserve pharmaceutical compositions
ES2125469T3 (en) ABSORBENT ITEMS WITH UNDERWEAR COVERING COMPONENTS PREPARED TO AUTOMATICALLY WRAP THE SIDES OF UNDERWEAR.
ES2125734T3 (en) USE OF A 2-AMINO-ALCANE-1,3-DIOL TO STOP THE HAIR LOSS AND / OR INDUCE AND STIMULATE ITS GROWTH.
DE60031016D1 (en) Use of antiseptics for the preparation of medicaments for the prophylaxis and treatment of inflammation in the interior of the human body
PT1001775E (en) MEDICATION CONTAINING IOIMBINE AND ARGININE FOR TREATMENT OF ERECTILE DISFUNCTION
AR016200A1 (en) THE USE OF A COMPOSITION THAT INCLUDES ONE OR MORE COMPOUNDS CONTAINING SULFUR FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO INCREASE THE PERMEABILITY OF THE HUMAN CORN FABRIC, AND A KIT THAT INCLUDES SUCH COMPOSITION
AR004077A1 (en) A PARTICULARLY COSMETIC COMPOSITION, AND MORE PARTICULARLY FOR THE PERMANENT DEFORMATION OF KERATINIC FIBERS.
SE7512231L (en) STERILIZER
ES2118726T3 (en) EPIDERMAL GROWTH FACTOR AS A MEDICATION FOR THE RESTORATION OF NEURONS OF THE NIGRA SUBSTANCE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS.
BR0016637A (en) Agent to combat parasites / depsipeptide